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The Hippo pathway is a conserved regulator of organ growth that has been implicated in cancer.
However, the upstream regulatory signals and exact cellular mechanisms of growth control are
poorly understood. In this Select, we highlight recent advances that provide mechanistic links
between Hippo signaling and cell proliferation, tissue invasion, and metastasis.Ras activation and mitochondrial dysfunction
(green) stimulate cell proliferation (magenta) of
surrounding cells (blue). Image courtesy of Tat-
sushi Igaki.Inhibiting Hippo Helps Neighbors Grow
Cell-autonomous growth control has been extensively studied in cancer;
however, the mechanisms through which cancer cells influence their
neighbors’ growth are poorly understood. A new study by Ohsawa
et al. finds that Hippo signaling is an integral component of a nonautono-
mous pathway for proliferation and invasion that is driven by oncogenic
Ras and oxidative stress. Using a fly eye overgrowth model, Ohsawa
et al. surprisingly find that mutations in mitochondrial genes can coop-
erate with Ras to drive proliferation in adjacent cells. Ras and mitochon-
drial dysfunction together cause oxidative stress, which suppresses
Hippo signaling and activates the downstream transcriptional coactivator,
Yorkie (YAP in humans). Yorkie upregulates Wingless (a Wnt homolog)
and Unpaired (a JAK/STAT ligand), which drive proliferation and invasion
in nearby cells that have active Ras but normal mitochondrial function.
Interestingly, no overgrowth is seen in the Ras-active and mitochondria-
defective cells themselves, perhaps due to mitochondrial dysfunction-
induced cell-cycle arrest. These results provide a potential mechanism
of cooperativity within genetically heterogeneous tumors. Furthermore,
they position the Hippo pathway as an important mediator for this effect.
Whether this mechanism is involved in cancer development remains to beseen; however, the high incidence of both Ras mutation and mitochondrial dysfunction in many types of cancer
make this a promising finding.
Ohsawa, S., et al. (2012). Nature 490, 547–551.Loss of LIFR causes lung metastasis of breast
cancer cells, which can be reversed by depletion
of YAP. Photos courtesy of Li Ma.Scribbling an Inhibitor of Metastasis
Although the number of known upstream regulators of Hippo signaling
is growing, few have been proven to be functionally important in
mammalian in vivo systems. A new study by Chen et al. provides
clear in vivo evidence linking the leukemia inhibitory factor (LIF)
membrane receptor (LIFR) to Hippo signaling. Initially identifying LIFR
as a novel target of miRNA-9, a metastasis-promoting miRNA, they
find that LIFR expression is both necessary and sufficient to inhibit
metastatic features in breast cancer cell lines. To further examine the
mechanisms through which LIFR suppresses metastasis, the authors
look downstream of the receptor. Although the LIFR-signaling mecha-
nisms are poorly understood, it was previously shown that LIF can
modulate phosphorylation of YAP, the main downstream effector of
Hippo signaling, through an unknown mechanism. Here, the mechanism is teased out: LIF signaling activates
Hippo by promoting membrane localization of the scaffold protein Scribble, which coordinates the signaling
cascade. This suppresses the transcriptional coactivator YAP, thereby preventing induction of metastasis-promoting
genes. Compellingly, LIFR expression strongly correlates with metastasis-free, recurrence-free, and over survival
outcomes among breast cancer patients; however, the activation status of Hippo has not yet been assessed in
primary human breast cancer tissue. Importantly, this study links Hippo signaling to the novel metastasis-suppressor
gene LIFR.
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Mo et al. suggest a role for a GPCR (rainbow) in
regulating Hippo signaling.A New GPCR PARtakes in Lats Regulation
As the number of known upstream regulators of the Hippo pathway prolif-
erates, a common theme is emerging: the actin cytoskeleton mediates
signaling to Hippo. In support of this, Mo et al. now show that thrombin,
through activation of the protease-activated receptor 1 (PAR1) G-protein-
coupled receptor (GPCR), regulates Hippo signaling through a filamentous
(F)-actin-dependent mechanism. PAR1 functions in wound healing and has
been implicated in tumor cell growth, invasion, and cancer metastasis,
providing another mechanistic link between the Hippo pathway and these
cancer functions. Similar to a previous study by this group that linked
GPCRs to Hippo signaling, the authors find that PAR1 must specifically
signal through the heterotrimeric G proteins G12/13 to regulate Hippo.
Also reinforcing their previous data, the mechanism involves Rho-depen-
dent F-actin formation, which bypasses the upstream kinase Mst1 (theHippo homolog) to inhibit its target, Lats1/2 (the Warts homolog). This leads to dephosphorylation and activation of
YAP. Importantly, activation of YAP is crucial for PAR-mediated induction of cell migration and invasion. High PAR1
expression has been observed in a variety of epithelial cancers; this evidence provides another potential mechanism
for Hippo regulation in cancers of epithelial origin. Interestingly, the mechanism through which F-actin formation can
inhibit Mst1/2 phosphorylation remains obscure. As Rho signaling and the cytoskeleton also mediate signals to Hippo
about extracellular matrix plasticity and cell shape, understanding how these Rho- and actin-dependent signals are
transduced to Hippo is a crucial open question in the field.
Mo, J.-S., et al. (2012). Genes Dev. 26, 2138–2143.Hipk expression (red) promotes Yki activity (white)
in the Drosophila melanogaster wing imaginal
disc. Images courtesy of Carole Poon and Kieran
Harvey.One HIP Yorkie
Most known regulators of the Hippo pathway signal to Hippo itself or its
downstream target Warts (Wts). Wts phosphorylates the transcriptional
coactivator Yorkie (Yki), which causes it to be sequestered in the cyto-
plasm by 14-3-3 proteins, blocking its function. Now, a kinase is shown
to bypass Wts and Hippo to positively regulate Yki activity. Two studies
use powerful fly genetics to discover that homeodomain-interacting
protein kinase (HIPK), a member of a conserved serine/threonine kinase
family, promotes tissue growth through activation of Yki. Importantly,
HIPK is required for some, but not all, of Yki activity, suggesting that it
is a modifier rather than a crucial regulator. Both Chen and Verheyen
(2012) and Poon et al. (2012) find that HIPK kinase activity is required
for this function and that it activates Yki either downstream or parallel
to Wts. However, there are some discrepancies in the controlling mech-
anism. Poon et al. find that HIPK activates Yki by promoting its nuclear
localization, although they did not detect a direct interaction between HIPK and Yki. By contrast, Chen and Verheyen
find no effect on Yki localization; rather, their results suggest that HIPK directly interacts with and phosphorylates
nuclear Yki, thus augmenting its activity. Importantly, Poon et al. show that the human HIPK homolog HIPK2 promotes
YAP abundance and activity, suggesting that this functional relationship is evolutionarily conserved. These results
open up a novel and unexplored route to Hippo signaling regulation. The mechanisms that regulate HIPK are poorly
understood; therefore, it will be interesting to see whether this mode of regulation integrates new signals into the
Hippo pathway response.
Chen, J., and Verheyen, E.M. (2012). Curr. Biol. 22, 1582–1586.
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